HIV drug Dolutegravir did not get Indian patent, the case was going on for many years
The Indian Patent Office has refused to grant a patent for dolutegravir. Dolutegravir is an important HIV medicine sold by ...
Read moreDetailsThe Indian Patent Office has refused to grant a patent for dolutegravir. Dolutegravir is an important HIV medicine sold by ...
Read moreDetailsSadabahar for Diabetes: The number of diabetes patients around the world is increasing rapidly. It is a disease related to ...
Read moreDetails© 2021 Aaj Samachar India.